Clayton-Smith, Jill http://orcid.org/0000-0002-9602-2321
Bromley, Rebecca
Dean, John
Journel, Hubert
Odent, Sylvie
Wood, Amanda
Williams, Janet
Cuthbert, Verna
Hackett, Latha
Aslam, Neelo
Malm, Heli
James, Gregory
Westbom, Lena
Day, Ruth
Ladusans, Edmund
Jackson, Adam
Bruce, Iain
Walker, Robert
Sidhu, Sangeet
Dyer, Catrina
Ashworth, Jane
Hindley, Daniel
Diaz, Gemma Arca
Rawson, Myfanwy
Turnpenny, Peter
Funding for this research was provided by:
CHAFEA (HP-ERN-SGA-2017 – 769045)
Article History
Received: 19 February 2019
Accepted: 12 April 2019
First Online: 19 July 2019
Authors’ information
: This project was only possible through a multidisciplinary approach. JCS, PT and JD are clinical geneticists with a long term interest in teratogenic effects of antiepileptic drugs. RB is a clinical psychologist and AW a developmental neuropsychologist with extensive clinical and research interests in this area. RD is a general practitioner looking after children and adults with learning disability in primary care. RD also has experience in dysmorphology and clinical genetics. VC is a senior physiotherapist who runs a specialist clinic for children with joint hypermobility. HM has a background in teratology and LB is a consultant paediatrician with a special interest in neural tube defects. GJ is a craniofacial surgeon who works in a specialist craniosynostosis team and IB is an academic ENT surgeon. RW is a consultant anaesthetist and AJ is a junior medical doctor who has undertaken previous research studies on the clinical and genetic aspects of Fetal Valproate Syndrome. CD is a speech and language therapist attached to one of the UK Cleft Networks and working in the community. LH and NA are child and adolescent psychiatrists, LH has a specific interest in autism spectrum disorder. JA is a paediatric ophthalmologist and DH is a consultant paediatrician with a special interest in neurodisability. SS is a clinical fellow in paediatric nephrology. GAD is a consultant neonatologist with a specific interest in congenital malformations and dysmorphology. EL is a paediatric cardiologist who has published in this area previously, MR is a research associate who works as data manager for the European Reference Network ERN ITHACA. This project came out of initial work by HJ and SO, clinical geneticists who prepared the French protocol for diagnosis and care on Fetal Valproate Syndrome. Finally, a very important contribution to this group came from JW who is a parent and coordinates a support group for families who have children affected by teratogenic effects of antiepileptic drugs.
: Ethics approval was not required for the purpose of drawing up these management recommendations.
: Signed consent for publication of the accompanying patient images was obtained from all of the patients concerned. Copies of consent forms available on request.
: All participants in the process were asked to declare any conflicts of interest or competing interests. The authors declared that they had no competing interests.